1,2,3,4-tetrahydroquinoline has been researched along with Migraine Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, J; Annedi, SC; Catalano, C; De Felice, M; Dove, P; Lee, DK; Maddaford, SP; Mladenova, G; Nair, S; Porreca, F; Rakhit, S; Ramnauth, J; Renton, P; Silverman, S; Speed, J; Zinghini, S | 1 |
1 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Migraine Disorders
Article | Year |
---|---|
Design, synthesis, and biological evaluation of 3,4-dihydroquinolin-2(1H)-one and 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors.
Topics: Animals; Humans; Hyperalgesia; Male; Migraine Disorders; Neuralgia; Nitric Oxide Synthase Type I; Quinolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2011 |